Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goldstein

Showing results (731-740 of 744) with videos related to

Pageof 75
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective AnalysisMax Gau, Jie Su, Shao Hui Huang, et al.
Annals of Surgical Oncology|October 29, 2024
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer OutcomesJacob Wihlidal, Alex O Esemezie, Shao Hui Huang, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Head & Neck|April 2, 2024
Telemedicine-enabled biofeedback electropalatography rehabilitation (TEBER): A pilot study for patients treated with surgery for oral cavity carcinomaDouglas B Chepeha, Carly E A Barbon, Alex O Esemezie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Cancer|August 12, 2020
Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemicJohn R de Almeida, Christopher W Noel, David Forner, et al.
Obesity (Silver Spring, Md.)|September 10, 2025
Toward Health Equity: A Workshop Report on the State of the Science of Obesity Interventions for AdultsLoneke T Blackman Carr, Jamy Ard, Carmen Byker Shanks, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
Pageof 75

Showing results (731-740 of 744) with videos related to

Sort By:
Pageof 75
International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective AnalysisMax Gau, Jie Su, Shao Hui Huang, et al.
Annals of Surgical Oncology|October 29, 2024
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer OutcomesJacob Wihlidal, Alex O Esemezie, Shao Hui Huang, et al.
The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Head & Neck|April 2, 2024
Telemedicine-enabled biofeedback electropalatography rehabilitation (TEBER): A pilot study for patients treated with surgery for oral cavity carcinomaDouglas B Chepeha, Carly E A Barbon, Alex O Esemezie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.
Cancer|August 12, 2020
Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemicJohn R de Almeida, Christopher W Noel, David Forner, et al.
Obesity (Silver Spring, Md.)|September 10, 2025
Toward Health Equity: A Workshop Report on the State of the Science of Obesity Interventions for AdultsLoneke T Blackman Carr, Jamy Ard, Carmen Byker Shanks, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2019
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2Linh T Nguyen, Samuel D Saibil, Valentin Sotov, et al.
Nature Communications|September 7, 2024
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization studyAbhinav Thakral, John Jw Lee, Tianzhichao Hou, et al.
Pageof 75